Published in J Pediatr Endocrinol Metab on March 01, 2004
Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab (2010) 1.73
Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children. J Pediatr (2006) 1.45
The stability of metabolic syndrome in children and adolescents. J Clin Endocrinol Metab (2009) 1.23
An evolving scientific basis for the prevention and treatment of pediatric obesity. Int J Obes (Lond) (2014) 1.00
Addition of orlistat to conventional treatment in adolescents with severe obesity. Eur J Pediatr (2004) 0.99
Treatment of obesity in children and adolescents. J Pediatr Pharmacol Ther (2012) 0.93
A clinic-based lifestyle intervention for pediatric obesity: efficacy and behavioral and biochemical predictors of response. J Pediatr Endocrinol Metab (2009) 0.90
Parent report of binge eating in Hispanic, African American and Caucasian youth. Eat Behav (2012) 0.88
Development of hypertension in overweight adolescents: a review. Adolesc Health Med Ther (2015) 0.88
Binge eating and weight-related quality of life in obese adolescents. Nutrients (2012) 0.84
Pharmacotherapy for childhood obesity: present and future prospects. Int J Obes (Lond) (2012) 0.83
Pharmacologic treatment of pediatric obesity. Can Fam Physician (2011) 0.79
Current approaches to the management of pediatric overweight and obesity. Curr Treat Options Cardiovasc Med (2014) 0.77
Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy. Diabetes Metab Syndr Obes (2009) 0.76
Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA (2002) 23.79
Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab (2000) 11.97
Risks and consequences of childhood and adolescent obesity. Int J Obes Relat Metab Disord (1999) 7.48
Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet (1998) 6.17
Long-term maintenance of weight loss: current status. Health Psychol (2000) 6.03
Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem (1993) 3.87
Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes (1989) 3.79
Emerging epidemic of type 2 diabetes in youth. Diabetes Care (1999) 3.74
Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res (2000) 3.60
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA (1999) 3.56
A new air displacement method for the determination of human body composition. Med Sci Sports Exerc (1995) 2.87
Weight-loss experience of black and white participants in NHLBI-sponsored clinical trials. Am J Clin Nutr (1991) 2.39
Evaluation of a new air displacement plethysmograph for measuring human body composition. Med Sci Sports Exerc (1995) 2.34
Emergence of type 2 diabetes mellitus in children: epidemiological evidence. J Pediatr Endocrinol Metab (2000) 2.12
Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab (1998) 2.07
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia. Eur J Clin Pharmacol (1994) 2.04
Weight loss with vertical banded gastroplasty and Roux-Y gastric bypass for morbid obesity with selective versus random assignment. Am J Surg (1989) 1.97
A longitudinal study of resting energy expenditure relative to body composition during puberty in African American and white children. Am J Clin Nutr (2001) 1.86
Orlistat in the long-term treatment of obesity in primary care settings. Arch Fam Med (2000) 1.77
Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab (2002) 1.69
Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care (1998) 1.58
Aetiology of overweight and obesity in children and adolescents. Eur J Pediatr (2000) 1.53
Determination of vitamin K compounds in plasma or serum by high-performance liquid chromatography using postcolumn chemical reduction and fluorimetric detection. Methods Enzymol (1997) 1.50
Insulin secretion and sensitivity in black versus white prepubertal healthy children. J Clin Endocrinol Metab (1997) 1.48
Effectiveness of a behavioral weight control program for blacks and whites with NIDDM. Diabetes Care (1996) 1.43
Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group. Obes Res (2000) 1.42
Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy (2000) 1.39
Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obes Res (2002) 1.34
Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones. N Engl J Med (1981) 1.30
One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. Int J Obes Relat Metab Disord (2000) 1.30
Changes in resting energy expenditure after weight loss in obese African American and white women. Am J Clin Nutr (1999) 1.27
Liquid-chromatographic assay for retinol (vitamin A) and retinol analogs in therapeutic trials. Clin Chem (1982) 1.23
Racial differences in energy expenditure and aerobic fitness in premenopausal women. Am J Clin Nutr (2000) 1.22
Comparison of air-displacement plethysmography with hydrostatic weighing and bioelectrical impedance analysis for the assessment of body composition in healthy adults. Am J Clin Nutr (1999) 1.18
A comparison of air displacement plethysmography with three other techniques to determine body fat in healthy adults. JPEN J Parenter Enteral Nutr (1999) 1.14
A study of body weight concerns and weight control practices of 4th and 7th grade adolescents. Ethn Health (2000) 1.13
Pubertal African-American girls expend less energy at rest and during physical activity than Caucasian girls. J Clin Endocrinol Metab (1999) 1.12
Treatment with orlistat reduces cardiovascular risk in obese patients. J Hypertens (1998) 1.10
Pharmacokinetics of highly ionized drugs. II. Methylene blue--absorption, metabolism, and excretion in man and dog after oral administration. J Pharm Sci (1972) 1.09
The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study. Int J Obes Relat Metab Disord (2001) 1.06
Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study. Orlistat Dose-Ranging Study Group. Eur J Clin Pharmacol (1998) 1.05
Body composition in children and adults by air displacement plethysmography. Eur J Clin Nutr (1999) 1.05
Self-esteem and adiposity in black and white girls: the NHLBI Growth and Health Study. Ann Epidemiol (1997) 1.03
Do African Americans have lower energy expenditure than Caucasians? Int J Obes Relat Metab Disord (2000) 1.03
Obesity-related knowledge, attitudes, and behaviors in obese and non-obese urban Philadelphia female adolescents. Obes Res (2001) 1.00
Resting metabolic rate in African-American and Caucasian girls. Obes Res (1997) 0.99
Whole body air displacement plethysmography compared with hydrodensitometry for body composition analysis. Arch Dis Child (2000) 0.99
Effects of orlistat on fat-soluble vitamins in obese adolescents. Pharmacotherapy (2002) 0.99
Comparison of air-displacement plethysmography, hydrodensitometry, and dual X-ray absorptiometry for assessing body composition of children 10 to 18 years of age. Ann N Y Acad Sci (2000) 0.99
The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study. J Intern Med (2000) 0.99
A one-year trial to assess the value of orlistat in the management of obesity. Int J Obes Relat Metab Disord (1997) 0.94
Development of a questionnaire for detecting potential adverse drug reactions. Ann Pharmacother (1992) 0.93
Minor long-term changes in weight have beneficial effects on insulin sensitivity and beta-cell function in obese subjects. Diabetes Obes Metab (2002) 0.89
QUICKI is a useful and accurate index of insulin sensitivity. J Clin Endocrinol Metab (2002) 0.89
Age, sex, ethnicity, body composition, and resting energy expenditure of obese African American and white children and adolescents. Am J Clin Nutr (2002) 0.89
Focus group data pertinent to the prevention of obesity in African Americans. Am J Med Sci (2001) 0.87
Cultural considerations for treatment of childhood obesity. J Cult Divers (2000) 0.86
Routine measurement of calcium, magnesium, copper, zinc, and iron in urine and serum by inductively coupled plasma emission spectroscopy. Clin Chem (1986) 0.85
Resting energy expenditure in African American and white children. Am J Clin Nutr (2001) 0.83
Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet Med (1993) 0.82
Orlistat inhibits dietary cholesterol absorption. Obes Res (2001) 0.81
Traditional coronary risk factors in African Americans. Am J Med Sci (1999) 0.81
Quantitation of serum tocopherols by high-performance liquid chromatography with fluorescence detection. J Chromatogr (1980) 0.81
Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns. Int J Obes Relat Metab Disord (2000) 0.80
First clinical studies with orlistat: a short review. Obes Res (1995) 0.76
A better index of body adiposity. Obesity (Silver Spring) (2011) 7.53
Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med (2008) 5.34
Obesity. N Engl J Med (2002) 4.29
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology (2004) 3.61
High adiposity and high body mass index-for-age in US children and adolescents overall and by race-ethnic group. Am J Clin Nutr (2010) 3.22
The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab (2004) 3.13
Brain-derived neurotrophic factor and obesity in the WAGR syndrome. N Engl J Med (2008) 2.91
Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes (2006) 2.87
Eating-disordered behaviors, body fat, and psychopathology in overweight and normal-weight children. J Consult Clin Psychol (2004) 2.37
A prospective study of psychological predictors of body fat gain among children at high risk for adult obesity. Pediatrics (2006) 2.28
Orthopedic complications of overweight in children and adolescents. Pediatrics (2006) 2.25
A prospective study of loss of control eating for body weight gain in children at high risk for adult obesity. Int J Eat Disord (2009) 1.93
Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab (2004) 1.92
Obesity prevalence in the United States--up, down, or sideways? N Engl J Med (2011) 1.91
A prospective study of pediatric loss of control eating and psychological outcomes. J Abnorm Psychol (2011) 1.89
The FTO gene rs9939609 obesity-risk allele and loss of control over eating. Am J Clin Nutr (2009) 1.88
Assessing weight-related quality of life in adolescents. Obesity (Silver Spring) (2006) 1.85
The perceived onset of dieting and loss of control eating behaviors in overweight children. Int J Eat Disord (2005) 1.78
Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc (2008) 1.77
Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency. J Clin Endocrinol Metab (2004) 1.73
A multisite investigation of binge eating behaviors in children and adolescents. J Consult Clin Psychol (2007) 1.72
Loss of control over eating, adiposity, and psychopathology in overweight children. Int J Eat Disord (2002) 1.71
Dry eye signs and symptoms in women with premature ovarian failure. Arch Ophthalmol (2004) 1.69
Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. Diabetes Care (2002) 1.68
Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development. Clin Endocrinol (Oxf) (2008) 1.67
Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates. JPEN J Parenter Enteral Nutr (2012) 1.64
Binge eating in overweight treatment-seeking adolescents. J Pediatr Psychol (2006) 1.64
Laboratory assessment of the food intake of children and adolescents with loss of control eating. Am J Clin Nutr (2009) 1.64
Health-related quality of life in overweight and nonoverweight black and white adolescents. J Pediatr (2005) 1.60
Insulin resistance, hyperinsulinemia, and energy intake in overweight children. J Pediatr (2008) 1.59
Psychological status and weight-related distress in overweight or at-risk-for-overweight children. Obesity (Silver Spring) (2006) 1.58
Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder. Am J Clin Nutr (2010) 1.58
Salience of loss of control for pediatric binge episodes: does size really matter? Int J Eat Disord (2010) 1.53
Venous thrombosis and conjugated equine estrogen in women without a uterus. Arch Intern Med (2006) 1.50
The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese Black Americans. Clin Endocrinol (Oxf) (2006) 1.50
Self-assessment of pubertal stage in overweight children. Pediatrics (2002) 1.48
Determining the waist circumference in african americans which best predicts insulin resistance. Obesity (Silver Spring) (2008) 1.44
Both subcutaneous and visceral adipose tissue correlate highly with insulin resistance in african americans. Obes Res (2004) 1.43
Disordered-eating attitudes in relation to bone mineral density and markers of bone turnover in overweight adolescents. J Adolesc Health (2009) 1.42
Hormonal responses and test meal intake among obese teenagers before and after laparoscopic adjustable gastric banding. Am J Clin Nutr (2013) 1.41
Which metric of relative weight best captures body fatness in children? Obes Res (2003) 1.39
Low bone mass in premenopausal women with depression. Arch Intern Med (2007) 1.38
Sex differences in visceral adipose tissue volume among African Americans. Am J Clin Nutr (2002) 1.35
Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obes Res (2002) 1.34
Bone mineral density in estrogen-deficient young women. J Clin Endocrinol Metab (2009) 1.33
Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial. Diabetes (2011) 1.32
Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes. J Clin Endocrinol Metab (2010) 1.32
Effects of binge eating on satiation, satiety, and energy intake of overweight children. Am J Clin Nutr (2006) 1.30
Influence of excess adiposity on exercise fitness and performance in overweight children and adolescents. Pediatrics (2005) 1.29
Comparison of assessments of children's eating-disordered behaviors by interview and questionnaire. Int J Eat Disord (2003) 1.29
Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertil Steril (2005) 1.26
Loss of control eating disorder in children age 12 years and younger: proposed research criteria. Eat Behav (2008) 1.25
The stability of metabolic syndrome in children and adolescents. J Clin Endocrinol Metab (2009) 1.23
Pediatric obesity: etiology and treatment. Endocrinol Metab Clin North Am (2009) 1.22
Challenges and opportunities of defining clinical leptin resistance. Cell Metab (2012) 1.21
Eating in the absence of hunger in adolescents: intake after a large-array meal compared with that after a standardized meal. Am J Clin Nutr (2010) 1.21
Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity. Diabetes (2005) 1.21
Validation of the emotional eating scale adapted for use in children and adolescents (EES-C). Int J Eat Disord (2007) 1.21
Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab (2004) 1.19
Psychometric properties of a new questionnaire to assess eating in the absence of hunger in children and adolescents. Appetite (2008) 1.19
A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia. Clin Endocrinol (Oxf) (2009) 1.17
Influence of serum leptin on weight and body fat growth in children at high risk for adult obesity. J Clin Endocrinol Metab (2006) 1.16
Diet and sex hormones in girls: findings from a randomized controlled clinical trial. J Natl Cancer Inst (2003) 1.15
Serum brain-derived neurotrophic factor concentrations in lean and overweight children and adolescents. J Clin Endocrinol Metab (2006) 1.14
Children's descriptions of the foods consumed during loss of control eating episodes. Eat Behav (2006) 1.14
Adiposity and human regional body temperature. Am J Clin Nutr (2009) 1.12
Comparison of methods to assess change in children's body composition. Am J Clin Nutr (2004) 1.11
Patients with Bardet-Biedl syndrome have hyperleptinemia suggestive of leptin resistance. J Clin Endocrinol Metab (2011) 1.10
Validation of three food frequency questionnaires to assess dietary calcium intake in adults. J Am Diet Assoc (2007) 1.10
Prevalence of overweight among inner city Hispanic-American children and adolescents. Obes Res (2004) 1.09
Calcium intake and adiposity. Am J Clin Nutr (2003) 1.04
Prolonging the female reproductive lifespan and improving egg quality with dietary omega-3 fatty acids. Aging Cell (2012) 1.04
Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children. Am J Clin Nutr (2011) 1.04
Comparison of the child and parent forms of the Questionnaire on Eating and Weight Patterns in the assessment of children's eating-disordered behaviors. Int J Eat Disord (2004) 1.03
Laboratory-Based Studies of Eating among Children and Adolescents. Curr Nutr Food Sci (2007) 1.03
The menstrual cycle: a biological marker of general health in adolescents. Ann N Y Acad Sci (2008) 1.03
Are gastrointestinal symptoms related to diabetes mellitus and glycemic control? Eur J Gastroenterol Hepatol (2008) 1.03
Energy intake and energy expenditure among children with polymorphisms of the melanocortin-3 receptor. Am J Clin Nutr (2009) 1.03
Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab (2004) 1.02
Quality of life and pain in premenopausal women with major depressive disorder: the POWER Study. Health Qual Life Outcomes (2006) 1.02
Estimates of body fat in children by Hologic QDR-2000 and QDR-4500A dual-energy X-ray absorptiometers compared with deuterium dilution. J Pediatr Gastroenterol Nutr (2006) 1.01